AstraZeneca Sues Mylan Over Entocort ANDA
AstraZeneca LP has sued Mylan Pharmaceuticals Inc. in an effort to prevent it from selling a generic version of Entocort EC, a drug used to treat Crohn's disease....To view the full article, register now.
Already a subscriber? Click here to view full article